FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
General Information
- Contract Opportunity Type: Special Notice (Updated)
- Updated Published Date: Nov 19, 2024 10:42 am EST
- Original Published Date: Oct 03, 2024 11:24 am EDT
- Updated Response Date: Feb 24, 2025 11:59 pm EST
- Original Response Date: Feb 24, 2025 11:59 pm EST
- Inactive Policy: Manual
- Updated Inactive Date: Sep 30, 2025
- Original Inactive Date: Sep 30, 2025
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Place of Performance: Silver Spring , MD 20993USA
Description
Amendment 02 - The BAA Notice has been updated to version 3 with various changes throughout.
Amendment 01 - The BAA Notice has been updated to version 2 with various changes throughout, and table 1 has been updated and included seperately.
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. Join us to learn more about the FY 2025 BAA, and how to apply.
Save the date for the 2024 FDA Broad Agency Announcement (BAA) Day! November 14th, 2024. BAA Day for FY25 2024 will be hosted on November 14th, 2024, as a virtual only event and will provide an opportunity to learn more about the application process and FDA’s priorities for regulatory research.
https://www.fda.gov/science-research/advancing-regulatory-science/2024-fda-broad-agency-announcement-day-11142024
Attachments/Links
Contact Information
Contracting Office Address
- 5630 Fishers Lane
- Rockville , MD 20857
- USA
Primary Point of Contact
- Ian Weiss
- Ian.Weiss@fda.hhs.gov
- Phone Number 3017965728
Secondary Point of Contact
History
- Dec 06, 2024 12:54 pm ESTSpecial Notice (Updated)
- Nov 19, 2024 10:42 am ESTSpecial Notice (Updated)
- Nov 15, 2024 09:14 am ESTSpecial Notice (Updated)
- Oct 03, 2024 02:20 pm EDTSpecial Notice (Updated)
- Oct 03, 2024 11:24 am EDTSpecial Notice (Original)